Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1978 Oct;40(10):1149–1152. doi: 10.1136/hrt.40.10.1149

Use of amiodarone in bradycardia-tachycardia syndrome.

A K Brown, R A Primhak, P Newton
PMCID: PMC483541  PMID: 708517

Abstract

Five patients with the bradycardia-tachycardia syndrome have been treated successfully with the antiarrhythmic agent amiodarone. Three patients were treated for over nine months and one of these patients had corneal micro deposits. One patient had to be taken off the drug because of side effects. Amiodarone should be tried in patients suffering from the bradycardia-tachycardia syndrome before resorting to cardiac pacing.

Full text

PDF
1149

Images in this article

1151Image
on p.1151

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Charlier R., Delaunois G., Bauthier J. Opposite effects of amiodarone and -blocking agents on cardiac function under adrenergic stimulation. Arzneimittelforschung. 1972 Mar;22(3):545–552. [PubMed] [Google Scholar]
  2. Ferrer M. I. The sick sinus syndrome. Circulation. 1973 Mar;47(3):635–641. doi: 10.1161/01.cir.47.3.635. [DOI] [PubMed] [Google Scholar]
  3. François J. Cornea verticillata. Doc Ophthalmol. 1969;27:235–251. doi: 10.1007/BF00208693. [DOI] [PubMed] [Google Scholar]
  4. Lustman F., Monseu G. Letter: Amiodarone and neurological side-effects. Lancet. 1974 Mar 30;1(7857):568–568. doi: 10.1016/s0140-6736(74)92757-3. [DOI] [PubMed] [Google Scholar]
  5. Olsson S. B., Brorson L., Varnauskas E. Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment. Br Heart J. 1973 Dec;35(12):1255–1259. doi: 10.1136/hrt.35.12.1255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Rosenbaum M. B., Chiale P. A., Halpern M. S., Nau G. J., Przybylski J., Levi R. J., Lázzari J. O., Elizari M. V. Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol. 1976 Dec;38(7):934–944. doi: 10.1016/0002-9149(76)90807-9. [DOI] [PubMed] [Google Scholar]
  7. Rubenstein J. J., Schulman C. L., Yurchak P. M., DeSanctis R. W. Clinical spectrum of the sick sinus syndrome. Circulation. 1972 Jul;46(1):5–13. doi: 10.1161/01.cir.46.1.5. [DOI] [PubMed] [Google Scholar]
  8. Singh B. N., Hauswirth O. Comparative mechanisms of action of antiarrhythmic drugs. Am Heart J. 1974 Mar;87(3):367–382. doi: 10.1016/0002-8703(74)90080-5. [DOI] [PubMed] [Google Scholar]
  9. Singh B. N., Vaughan Williams E. M. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol. 1970 Aug;39(4):657–667. doi: 10.1111/j.1476-5381.1970.tb09891.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Van Schepdael J., Solvay H. L'amiodarone dans le traitement des troubles du rythme cardiaque. Schweiz Rundsch Med Prax. 1975 Jan 14;64(2):30–34. [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES